Andrea Necchi, Head of Genitourinary Medical Oncology at Ospedale San Raffaele, shared on X:
“This further ESMO26 simultaneous publication is very important for me.
Outcomes of pts with MIBC who decline RC in perioperative setting:
Take-home message:
- cCR (Milan criteria) is a reliable biomarker and indicator of outcomes with Systemic Rx and reTURBT.
- Pts who do not get cCR could have a very poor prognosis under bladder-saving approaches > intensification with RC/chemoRT is very much needed.
Looking forward to ongoing trials (eg EV209, EV309). Congrats to the entire team, also getting Best Poster!”
Title: Outcomes of patients with muscle-invasive bladder cancer who declined radical cystectomy in perioperative therapy trials conducted at San Raffaele Comprehensive Cancer Center
Authors: Chiara Mercinelli, Giuseppe Basile, Michela Piacentini, Antonio Cigliola, Brigida A. Maiorano, Debora Serafin, Emanuele Crupi, Gualtiero Guandalini, Giovanni L. Pastorino, Gaia Latini, Pietro Scilipoti, Giovanni Tremolada, Marco Moschini, Giorgio Brembilla, Francesco De Cobelli, Maurizio Colecchia, Alberto Briganti, Francesco Montorsi, Andrea Necchi
You can also read:
KEYNOTE-B15/EV-304: Can ctDNA Predict Outcomes in MIBC?
